1. Allegra, J.C., Lippman, M.E., Thompson, E.B., Simon, R., Barlock, A., Green, L., Huff, K.K., Do, H.M.T., and Aitken, S.C., 1979a, Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast-cancer, Cancer Res. 39: 1447–1454.
2. Allegra, J.C., Lippman, M.E., Thompson, E.B., Simon, R., Barlock, A., Green, L., Huff, K.K., Do, H.M.T., Aitken, S.C., and Warren, R., 1979b, Relationship between the progesterone, androgen, and glucocorticoid receptor and response rate to endocrine therapy in metastatic breast cancer, Cancer Res. 39: 1973–1979.
3. Asselin, J., and Melançon, R., 1977, Characteristics of androgen binding in rat adrenal tissue using (3H)methyltrienolone (R1881) as tracer, Steroids
30: 591–604.
4. Asselin, J., Labrie, F., Gourdeau, Y., Bonne, C., and Raynaud, J.P., 1976a, Binding of (3H)methyltrienolone (R 1881) in rat prostate and human benign prostatic hypertrophy (BPH), Steroids
28: 449–459.
5. Asselin, J., Labrie, F., Kelly, P.A., Philibert, D., and Raynaud, J.P., 1976b, Specific progesterone receptors in dimethylbenzanthracene (DMBA)-induced mammary tumors, Steroids
27:395–404.